Assessment of the efficacy of novel inhibitors against pancreatic cancer

Research unit

INNOSUISSE

Project number

40922.1 IP-LS

Project title

Assessment of the efficacy of novel inhibitors against pancreatic cancer

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	Assessment of the efficacy of novel inhibitors against pancreatic cancer
Short description (English)	Assessment of the efficacy of novel inhibitors against pancreatic cancer
Abstract (German)	Pancreatic cancer (PDAC) is marked by rich desmoplastic stroma and immunosuppression. The proposed project will deliver mechanistic information and efficacy data of two novel inhibitors of PDAC, providing a strong rationale for entering clinical studies in PDAC patients with these therapeutics.